Sex and gender differences in pharmacology /

This is the very first book to deal with sex and gender differences in drug therapy - an increasingly recognized medical need. It starts with an overview on S/G in clinical syndromes and a documentation of the medical and socioeconomic damage caused by gender specific adverse drug effects. Part I co...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Regitz-Zagrosek, Vera
Format: eBook
Language:English
Published: Berlin, Heidelberg Springer Berlin Heidelberg 2012.
Series:Handbook of Experimental Pharmacology 214
Subjects:
Online Access:Click here to view the full text content
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02467nam a2200397 i 4500
001 vtls000105827
003 MY-ArUMP
005 20210731152133.0
006 m fo d
007 cr nn 008mamaa
008 121130s2012 gw | fs |||| 0|eng d
020 |a 9783642307263 
039 9 |a 201311241335  |b SMI  |c 201211302246  |d NY  |y 201211141234  |z SMR 
040 |a MYPMP  |b eng  |c MYPMP  |e rda 
245 1 0 |a Sex and gender differences in pharmacology /  |c edited by Vera Regitz-Zagrosek. 
264 1 |a Berlin, Heidelberg  |b Springer Berlin Heidelberg  |c 2012. 
300 |a 1 online resource (IX, 600 pages)  |b 37 illustration, 22 illustration in colour, digital. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 0 |a Handbook of Experimental Pharmacology  |x 0171-2004  |v 214 
520 |a This is the very first book to deal with sex and gender differences in drug therapy - an increasingly recognized medical need. It starts with an overview on S/G in clinical syndromes and a documentation of the medical and socioeconomic damage caused by gender specific adverse drug effects. Part I covers S/G differences in pharmacokinetics. Researchers will be satisfied by the detailed discussion of the mechanisms of S/G differences in drug effects that represents cutting edge science and includes interaction of drugs with sex hormones, genomic and epigenetic mechanisms. It also covers S/G in drug development, in animal models and clinical development and S/G in drug prescriptions. Part II targets S/G differences in drug effects in cardiovascular, pulmonary, CNS, neuromuscular, neuropsychiatric and metabolic diseases, in cancer, inflammation, and rheumatic diseases, in bacterial and retroviral infections, thrombosis, embolism. New drugs will be discussed. 
650 0 |a Medicine. 
650 0 |a Toxicology. 
650 0 |a Pharmaceutical  |x Technology. 
700 1 |a Regitz-Zagrosek, Vera. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642307256 
830 0 |a Handbook of Experimental Pharmacology  |x 0171-2004  |v 214 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-30726-3  |y Click here to view the full text content 
942 |2 lcc  |c BK-EBOOK 
949 |a VIRTUAITEM  |d 10011  |f 1  |x 9 
999 |c 49168  |d 49168 
952 |0 0  |1 0  |2 lcc  |4 0  |7 0  |9 44803  |a FSGM  |b FSGM  |d 2021-07-31  |l 0  |r 2021-07-31  |t 1  |w 2021-07-31  |y BK-EBOOK